Calumet Specialty Products Partners (CLMT) Reports Q1 Loss of $0.01/Share

Calumet Specialty Products Partners (NASDAQ: CLMT) reported Q1 EPS of ($0.01), versus ($0.04) reported last year. Revenue for the quarter came in at $851.3 million, versus $750.5 million reported last year.

For earnings history and earnings-related data on Calumet Specialty Products Partners (CLMT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c